Eurofins Discovery, a provider of services and products to the drug discovery industry, has formed a collaboration with Escient Pharmaceuticals. Eurofins Discovery’s integrated services are marketed under the brand name of DiscoveryOne.   Escient recently launched in San Diego with $40 million in Series A financing and is leveraging Eurofins’ expertise in assay development and GPCR drug discovery to identify novel therapeutics targeting Mas-Related G-Protein Receptors (Mrgpr). Under the te...